
Pembrolizumab (Keytruda)
Author(s) -
CADTH
Publication year - 2022
Publication title -
canadian journal of health technologies
Language(s) - Uncategorized
Resource type - Journals
ISSN - 2563-6596
DOI - 10.51731/cjht.2022.474
Subject(s) - medicine , nephrectomy , renal cell carcinoma , pembrolizumab , adjuvant , systemic therapy , kidney cancer , cancer , oncology , adjuvant therapy , immunotherapy , surgery , kidney , breast cancer